Several earlier reports have dealt with immunological abnormalities in epileptic patients. Low serum levels of IgA were most often described (Sorrell et al., 1971; Grob and Herold, 1972; Slavin et al., 1974; Aarli and Tonder, 1975; Buckley, 1975; Seager et al., 1975; Aarli, 1976; Kanoh and Uchino, 1976; Masi et al., 1976; Andersen and Mosekilde, 1977) . Immune reactions dependent on T-lymphocytes have also been shown to be abnormal in some epileptic patients as evidenced by absent delayed-type skin tests to various ubiquitous antigens, diminished lymphocyte stimulation by plant mitogens, and a decrease of circulating T cells (Sorrell et al., 1971; Massimo et al., 1976) . There are still many questions to be answered, such as whether only certain forms or stages of epilepsy are associated with immunodeficiencies, or whether anticonvulsant drugs especially hydantoins, are mainly responsible for, or at least add to the genesis of, the immunity abnormalities. Little is known about the exact nature of the immunological defects. We recently reported subnormal serum levels of IgA in 20-25% of patients with epilepsy characterised by the presence of constitutional factors for seizures, most of them being treated with hydantoins. In contrast IgA deficiency was never encountered in epileptics whose disease was thought to be secondary to traumatic, infectious, or metabolic Supported by the Swiss National Science Foundation (Grant number 3.077-0.76).
events even when comparable doses of hydantoins were given (Fontana et al., 1976; Ariizumi et al., 1977) . Further studies showed that if there is one IgA deficient epileptic member in a family in whom the disease is clustered, 85% of all other epileptics of the same family have low serum IgA, including some patients without hydantoin medication (Fontana et al., 1978) . Thus the association of low serum IgA and epilepsy seems to be consistent at least in some groups of patients.
In order to characterise further the nature of the immunological abnormality in IgA deficient epileptics, some additional parameters were tested.
Patients and methods
Twenty-three patients were studied from a group of 52 IgA deficient epileptics described in previous studies (Fontana et al., 1976 (Fontana et al., , 1978 (Skvaril, 1972 Tables 1, 2 , and 3. Of the 23 individuals tested, 13 were males and 10 females with an average age of 19 years. Five patients had not taken hydantoins for at least three years before testing. In three out of 23 patients tested, the average serum IgA levels were below the limit of detection (<0.05 mg/ml). In the other 20 patients the IgA level was lower than 0.6 mg/ml, a limit well below the mean -2 SD value (2.4-1.6 mg/ml). In most patients IgA was the only immunoglobulin class decreased, except in three individuals in whom one or two other immunoglobulin classes were also low.
Nineteen of 21 patients showed imbalance of one or more IgG subclasses. Diminution of serum IgG4 below the limit of detection was the most common abnormality and was seen in 13 (65%) of the 21 epileptics tested. In two patients the absence of IgG4 from the serum was accompanied by decreased IgGI or IgG2 respectively, and in three others by simultaneous elevation of serum IgGI and IgG3.
The blood lymphocytes of 21 of the 23 patients were tested for surface-bound immunoglobulins. The percentage of IgA (a-heavy chain) positive cells was normal in 16 individuals (67%). It was slightly increased above the mean +2 SD limit of 6% in six patients (28.5%). The percentage of cells positive for Ig when using a polyvalent antiIg serum and of those cells staining with antisera against y-or p,-heavy chain, X-or K-light chain, never surpassed the mean +2 SD limit. Immunological abnormalities and HLA antigen frequencies in IgA deficient patients 
Discussion
The individuals included in this study represent a narrow selection of epileptic patients. All showed clinical and electroencephalographic features of constitutional factors for seizures and all had low serum IgA. The most striking further abnormality seen in such patients was the diminished serum levels of IgG4 observed in 65% of our patients. IgG subclass abnormalities similar to those found in our series have not been observed in healthy blood donors. However, a high incidence of a deficiency of serum IgG4 has been described in patients with primary hypogammaglobulinaemia and in their relatives, and in non-epileptic individuals with a selective IgA deficiency (Yount et al., 1970; Morell et al., 1975; Yount, 1975; Van der Giessen et al., 1976) . Furthermore, patients with multiple sclerosis and subacute sclerosing panencephalitis also have low or undetectable serum IgG4 levels (Vandvik et al., 1976) . In these conditions several lines of evidence point to a relative displacement of IgG4, IgG2, and IgG3 by oligoclonal IgGI proteins.
The percentages of surface Ig positive cells were normal except in six patients with slightly raised values for IgA (a-chain) positive elements. These findings are in accordance with those of other workers who also found normal or elevated numbers of IgA positive cells in patients with selective IgA deficiency (Lawton et al., 1972; Buckley, 1975) . Our data may add to an earlier observation of twin children who both had epilepsy: one child was under hydantoin medication and had low serum IgA with normal IgA bearing lymphocytes, while the other, who was not being treated with hydantoins, had a normal serum IgA concentration but highly elevated IgA bearing cells (Fontana et al., 1978) . Although our data and those from others concerning elevated IgA bearing cells seem to be valid, they are difficult to interpret. According to present knowiedge neither true IgG nor IgA receptors exist on B-lymphocytes (Kunkel, 1976) , leaving the possibility of augmented numbers of Fc-receptor (Massimo et al., 1976) . In most of the patients without an associated seizure disorder no T-cell defect was observed (Buckley, 1975; Delespesse et al., 1976) . IgA deficiency and thymus abnormalities (also evidenced by low levels of circulating T-cells) are encountered in ataxia telangiectasia (McFarlin et al., 1972; Buckley, 1975) and in congenital myasthenia gravis, a disease form beginning in the first years of life with frequent familial clusters (Bundey et al., 1972; Behan et al., 1976) .
Until recently the existence of a genetic factor in epilepsy was mainly suggested by the occasional familial disease clustering. At least in IgA deficient epileptics another argument is now introduced by a possible association with HLA-A2 antigen. Although our data appear to be significant, further patients have to be tested for conformation of an HLA-A2 association. When multiplying the x2-value by the number of antigens tested (26), as recommended, a P value of 0.13 results. So far most of the known associations between HLA antigens and diseases concern the HLA B-locus. This is also true for another seizure disorder, the Lennox-Gastaut syndrome, for which a significant association with HLA-B7 has been reported (Smeraldi et al., 1975 (Sorrell et al., 1971; Aarli et al., 1975; Seager et al., 1975) . However, our data (Fontana et al., 1978) and those of Seager et al., (1975) 
